{"url_path":"/sec/cik-0001440153/8-k/2026-06-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1440153/0001096906-26-001026-index.html","accession_number":"0001096906-26-001026","cik":"0001440153","ticker":null,"issuer_name":"Bakhu Holdings, Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1440153/0001096906-26-001026-index.html","primary_entity_key":"0001440153","primary_entity_name":"Bakhu Holdings, Corp."},"word_count":134,"has_tables":true,"body_markdown":"**ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS**\n\n \n\n**(d)**           **Exhibits**. The following exhibits are either filed as a part hereof or are incorporated by reference. Exhibit numbers correspond to the numbering system in Item 601 of Regulation S-K.\n\n \n\n**Exhibit**\n\n \n\n**Number**\n\n**Description of Exhibit**\n\n10.1\n\n[March 17, 2026 Memorandum of Understanding between Bakhu,](bkhu_ex10z1.htm)[Phytocyte](bkhu_ex10z1.htm)[and Inter-M Traders](bkhu_ex10z1.htm)[(1)](bkhu_ex10z1.htm)\n\n \n\n \n\n10.2\n\n[March 18, 2026 Indemnification, Hold Harmless and Advancement Letter Agreement](bkhu_ex10z2.htm)[(1)](bkhu_ex10z2.htm)\n\n \n\n \n\n10.3\n\n[April 17, 2026 Binding Heads of Agreement](bkhu_ex10z3.htm)[(1)](bkhu_ex10z3.htm)\n\n(1)  Filed herewith\n\nPage 8\n\n \n\n**SIGNATURE**\n\n \n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n**BAKHU HOLDINGS, CORP.**\n\n \n\n \n\n \n\n \n\nDated: May 28, 2026\n\n/s/ Konstantia Galazi\n\n \n\nBy: Konstania Galazi\n\n \n\nTitle: President and Chief Executive Officer\n\n \n\n(Principal Executive Officer)\n\nPage 9"}